Eliezer Van Allen, Chandra Nohria Family Chair for AI in Cancer Research at Dana-Farber Cancer Institute, Professor of Medicine at Harvard Medical School, shared a post on LinkedIn:
“Here’s our latest: A deep dive into how tumor and immune cells react to immunotherapy and chemotherapy in breast cancer – congrats Jingxin Fu, Sara Tolaney, Daniel Abravanel, Dr. Ada Waks et al.”
Title: Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer
Authors: Jingxin Fu, Adrienne G. Waks, Erica Pimenta, Breanna Titchen, Kevin Bi, Sabrina Camp, Theodora Pappa, Tanya Keenan, Erin Shannon, Sébastien Vigneau, Meredith Bemus, Anwesha Nag, Aaron R. Thorner, Jihye Park, Molly DiLullo, Eileen Wrabel, Rinath Jeselsohn, Elizabeth A. Mittendorf, Daniel L. Abravanel, Sara M. Tolaney, Eliezer M. Van Allen
Read the Full Article.

More from Eliezer Van Allen on OncoDaily.